Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study

Author:

Markby Jessica,Shilton SonjelleORCID,Sem Xiaohui,Chan Huan Keat,Md Said Rosaida,Siva Sasikala,Zainuddin Zalwani,Abu Bakar Norasiah,Omar Haniza,Ruiz Ryan Jose III,Gaeddert Mary,Tyshkovskiy Alexander,Adee Madeline,Chhatwal JagpreetORCID,Kumar Suresh,Piedagnel Jean-Michel,Mohd Zain Rozainanee,Menétrey Caroline,Yuswan Fazidah,Hairizan Nasir Nazrila,Andrieux-Meyer Isabelle,Ismail Fatanah,Zakaria Rozita,Hasim Ruziaton,Murad Shahnaz,Easterbrook Philippa,Hassan Muhammad Radzi Abu

Abstract

IntroductionTo achieve the elimination of hepatitis C virus (HCV), substantial scale-up in access to testing and treatment is needed. This will require innovation and simplification of the care pathway, through decentralisation of testing and treatment to primary care settings and task-shifting to non-specialists. The objective of this study was to evaluate the feasibility and effectiveness of decentralisation of HCV testing and treatment using rapid diagnostic tests (RDTs) in primary healthcare clinics (PHCs) among high-risk populations, with referral of seropositive patients for confirmatory viral load testing and treatment.MethodsThis observational study was conducted between December 2018 and October 2019 at 25 PHCs in three regions in Malaysia. Each PHC was linked to one or more hospitals, for referral of seropositive participants for confirmatory testing and pretreatment evaluation. Treatment was provided in PHCs for non-cirrhotic patients and at hospitals for cirrhotic patients.ResultsDuring the study period, a total of 15 366 adults were screened at the 25 PHCs, using RDTs for HCV antibodies. Of the 2020 (13.2%) HCV antibody-positive participants, 1481/2020 (73.3%) had a confirmatory viral load test, 1241/1481 (83.8%) were HCV RNA-positive, 991/1241 (79.9%) completed pretreatment assessment, 632/991 (63.8%) initiated treatment, 518/632 (82.0%) completed treatment, 352/518 (68.0%) were eligible for a sustained virological response (SVR) cure assessment, 209/352 (59.4%) had an SVR cure assessment, and SVR was achieved in 202/209 (96.7%) patients. A significantly higher proportion of patients referred to PHCs initiated treatment compared with those who had treatment initiated at hospitals (71.0% vs 48.8%, p<0.001).ConclusionsThis study demonstrated the effectiveness and feasibility of a simplified decentralised HCV testing and treatment model in primary healthcare settings, targeting high-risk groups in Malaysia. There were good outcomes across most steps of the cascade of care when treatment was provided at PHCs compared with hospitals.

Funder

Unitaid

Publisher

BMJ

Subject

General Medicine

Reference35 articles.

1. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

2. World Health Organization . Guidelines on hepatitis B and C testing, 2017. Available: http://www.who.int/hepatitis/publications/guidelines-hepatitis-c-b-testing/en/

3. World Health Organization . Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021, 2021. Available: https://www.who.int/publications/i/item/9789240027077

4. World Health Organization . Global health sector strategy on hepatitis 2016–2021, 2016. Available: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf

5. World Health Organization . Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, 2018. Available: https://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf?ua=1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3